Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 2, 2014 - Issue 1
Journal homepage
329
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Pricing and reimbursement of novel oncology drugs in Sweden

Mattias HaglundIIB Partner AB, Sweden. Email: [email protected]
&
Eric MillerOptio Biopharma SolutionsLLC, USA
Article: 25925 | Published online: 09 Dec 2014

References

  • Cohen J , Felix A . Are payers treating orphan drugs differently?. J Mark Access Health Pol. 2014; 2: 23513. doi: http://dx.doi.org/10.3402/jmahp.v2.23513 .
  • Picavet E , Annemans L , Cleemput I , Cassiman D , Simoens S . Market uptake of orphan drugs – A European analysis. J Clin Pharm Ther. 2012; 37: 664–7. [PubMed Abstract].
  • Garau M , Mestre-Ferrandiz J . Access mechanisms for orphan drugs: A comparative study of selected European countries. OHE Brief. 2009; 52: 1–24.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.